Champions Oncology Inc (CSBR)

1.85
NASDAQ : Health Care
Prev Close 1.85
Day Low/High 0.00 / 0.00
52 Wk Low/High 1.59 / 9.00
Avg Volume 12.40K
Exchange NASDAQ
Shares Outstanding 11.24M
Market Cap 21.58M
EPS -1.30
Div & Yield N.A. (N.A)

Icahn School Of Medicine At Mount Sinai And Champions Oncology Initiate Study Evaluating TumorGrafts' Ability To Predict Treatment Benefit In Patients With Triple-Negative Breast Cancer

Side-By-Side Genomic Analysis of Patients' Tumor and TumorGraft Mouse Avatars Before and After Treatment Also to be Conducted

Publication Of Article In Cancer Supports Use Of Personalized Mouse Avatars To Predict Treatment Benefit In Patients

Champions TumorGraftsa¿¢ Provide Accurate Predictions of Treatments' Efficacy in 81 Percent of Evaluated Patients with Advanced Sarcoma